Wegovy Wegovy and Ozempic are both once-weekly semaglutide injections
Cancer 143 (11), 26872697
It belongs to a class of drugs known as GLP-1 receptor agonists, which work by mimicking the effects of the hormone GLP-1 (glucagon-like peptide-1)
More serious but less common effects may include pancreatitis, gallbladder issues, kidney complications, and hypoglycemia
But doctors are reluctant to do that because they must monitor patients' weight loss and overall health while on the medication, she said
Vishal Manchanda, equity research analyst-pharma, Systemix Group, explains the significance: "The advantage with non-peptide is that they can be quickly scaled up and cost less to produce." Swapnil Shah, MD of Senores Pharma, adds a cautionoral GLP-1s are not standard small molecules